The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis: II. MRI analysis results of a multicenter, randomized, double‐blind, placebo‐controlled trial
Open accessAbstract
We performed yearly MRI analyses on 327 of the total 372 patients in a multicenter, randomized, double-blind, placebo-controlled trial of interferon beta-1b (IFNB). Clinical results are presented in the preceding companion paper. Baseline MRI characteristics were the same in all treatment groups. Fifty-two patients at one center formed a cohort for frequent MRIs (one every 6 weeks) for analysis of disease activity. The MRI results support the clinical results in showing a significant reduction in disease activity as measured by numbers of active scans (median 80% reduction, p = 0.0082) and appearance of new lesions. In addition, there was an equally significant reduction in MRI-detected burden of disease in the treatment as compared with placebo groups (mean group difference of 23%, p = 0.001). These results demonstrate that IFNB has made a significant impact on the natural history of MS in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Girard, M., Duquette, P., & Sibley, W. A. (1993) · Cited by 1,196
SERIAL GADOLINIUM ENHANCED MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS
MILLER, D. H., RUDGE, P., JOHNSON, G., KENDALL, B. E., MACMANUS, D. G., MOSELEY, I. F., BARNES, D., & MCDONALD, W. I. (1988) · Brain · doi:10.1093/brain/111.4.927 · Cited by 407
Miller, D. H., Barkhof, F., Berry, I., Kappos, L., Scotti, G., & Thompson, A. J. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.8.683 · Cited by 370
Noseworthy, J. H., Vandervoort, M. K., Wong, C. J., & Ebers, G. C. (1990) · Neurology · doi:10.1212/wnl.40.6.971 · Cited by 328
Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.
Thompson, A. J., Kermode, A. G., MacManus, D. G., Kendall, B. E., Kingsley, D. P., Moseley, I. F., & McDonald, W. I. (1990) · BMJ · doi:10.1136/bmj.300.6725.631 · Cited by 288
Willoughby, E. W., Grochowski, E., Li, D. K. B., Oger, J., Kastrukoff, L. F., & Paty, D. W. (1989) · Annals of Neurology · doi:10.1002/ana.410250107 · Cited by 254
Self-citationThe Multiple Sclerosis Study Group, & Wolinsky (1990) · Annals of Neurology · doi:10.1002/ana.410270603 · Cited by 217
Self-citationMultiple sclerosis: A serial study using MRI in relapsing patients
Isaac, C., B. Li, D. K., Genton, M., Jardine, C., Grochowski, E., Palmer, M., Kastrukoff, L. F., Oger, J., & Paty, D. W. (1988) · Neurology · doi:10.1212/wnl.38.10.1511 · Cited by 189
Self-citationScales for rating impairment in multiple sclerosis: A critique
Willoughby, E. W., & Paty, D. W. (1988) · Neurology · doi:10.1212/wnl.38.11.1793 · Cited by 158
Self-citationSerial study of gadolinium‐DTPA MRI enhancement in multiple sclerosis
Bastianello, S., Pozzilli, C., Bernardi, S., Bozzao, L., Fantozzi, L. M., Buttinelli, C., & Fieschi, C. (1990) · Neurology · doi:10.1212/wnl.40.4.591 · Cited by 113
Chronic progressive multiple sclerosis: Serial magnetic resonance brain imaging over six months
Koopmans, R. A., Li, D. K. B., Oger, J. J.-F., Kastrukoff, L. F., Jardine, C. M., Costley, L., Hall, S., Grochowski, E., & Paty, D. W. (1989) · Annals of Neurology · doi:10.1002/ana.410260211 · Cited by 91
Self-citationKastrukoff, L. F., Oger, J. J.-F., Hashimoto, S. A., Sacks, S. L., Li, D. K., Palmer, M. R., Koopmans, R. A., Petkau, A. J., Berkowitz, J., & Paty, D. W. (1990) · Neurology · doi:10.1212/wnl.40.3_part_1.479 · Cited by 77
Self-citationMagnetic resonance imaging in the evaluation of treatment in multiple sclerosis
Kappos, L., St�dt, D., Ratzka, M., Keil, W., Schneiderbanger-Grygier, S., Heitzer, T. A., Poser, S., & Nadjmi, M. (1988) · Neuroradiology · doi:10.1007/bf00328179 · Cited by 59
Neuroimaging in multiple sclerosis
Paty, D. W., & Li, D. K. B. (1988) · Frontiers of clinical neuroscience · Cited by 7
Self-citation
Cited by
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Polman, C. H., O'Connor, P. W., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., Lublin, F. D., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,386
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544
Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis
Jacobs, L. D., Cookfair, D. L., Rudick, R. A., Herndon, R. M., Richert, J. R., Salazar, A. M., Fischer, J. S., Goodkin, D. E., Granger, C. V., Simon, J. H., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390304 · Cited by 2,450
Metadata
- Authors
- Paty, D. W., Li, D. K. B., the UBC MS/MRI Study Group, & the IFNB Multiple Sclerosis Study Group
- Venue
- Neurology
- Published
- 1993-04
- Volume
- 43
- Issue
- 4
- Pages
- 662-662
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2165547142
- Cited by
- 1,967
- References
- 15
- FWCI
- 58.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.